Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
CNTX.OQ - Context Therapeutics Inc
Context Therapeutics Inc to Discuss CTIM-76 Phase 1 Interim Results
Jun 15, 2026 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning, everyone, and thank you for standing by. Welcome to the Context Therapeutics CTIMS 76 Phase 1 Interim Clinical Data Call. Please be advised that today's call is being recorded. I would now like to hand the call over to your host for today, Jennifer Manai, Context's Chief Financial Officer. Please go ahead.
--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Good morning and thank you for joining us. Before we begin, I would like to remind everyone that during this call, we will be making forward-looking statements. Because forward
